Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534167 · ClinicalTrials.gov registry record · NA
TODAY! A Mobile App Study
A NA study of Depression, Anxiety, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03534167: Completed NA study of Depression, Anxiety, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT03534167 is a NA study of Depression, Anxiety that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 22 participants, below the 424-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03534167, a NA study of Depression, Anxiety, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and minority stressors and treat anxiety and depression in young men romantically/sexually attracted to men.
Primary Outcome
The PHQ-9 is a brief validated depression module. This study will measure change in PHQ-9 scores.
Conditions Studied
Interventions
- BEHAVIORAL TODAY! App and Coaching
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT03534167 record still lists
NCT03534167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 424-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Depression, Anxiety appearing as the primary indexed condition, and to 1 intervention - of which TODAY! App and Coaching is the first listed.
NCT03534167 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03534167 about?
NCT03534167 is a clinical study titled "TODAY! A Mobile App Study". The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and minority stressors and treat anxiety and depression in young men romantically/sexually attracted to men.
What is the current status of trial NCT03534167?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-06-04. Estimated completion is 2022-06-30.
What conditions does trial NCT03534167 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT03534167?
The interventions under investigation include: TODAY! App and Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03534167?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03534167 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03534167's enrollment target sits among peer trials
22 37th of 40 higher than 4 of 40 other Depression, Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
Test of Target Engagement of Ambiguity Aversion
RECRUITING · NA
-
SUpport From PEeRs to Expand Access Study - Community
RECRUITING · NA
-
Building Connections
RECRUITING · NA
-
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI